Amgen (AMGN) Free Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
36.22% |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,827.56% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-56.64% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
154.57% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
149.74% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
50.71% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
46.82% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
23.04% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-55.31% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
50.71% |
| Dec 31, 2025 |
-78.16% |
| Sep 30, 2025 |
28.18% |
| Jun 30, 2025 |
-13.96% |
| Mar 31, 2025 |
113.51% |
| Dec 31, 2024 |
1,422.49% |
| Sep 30, 2024 |
31.93% |
| Jun 30, 2024 |
-42.13% |
| Mar 31, 2024 |
-36.25% |
| Dec 31, 2023 |
-87.48% |
| Sep 30, 2023 |
-10.86% |
| Jun 30, 2023 |
127.91% |
| Mar 31, 2023 |
-63.53% |
| Dec 31, 2022 |
-8.41% |
| Sep 30, 2022 |
29.50% |
| Jun 30, 2022 |
-3.55% |
| Mar 31, 2022 |
1.86% |
| Dec 31, 2021 |
27.32% |
| Sep 30, 2021 |
-32.69% |
| Jun 30, 2021 |
-34.95% |
| Mar 31, 2021 |
-2.71% |
| Dec 31, 2020 |
-14.88% |
| Sep 30, 2020 |
0.81% |
| Jun 30, 2020 |
111.34% |
| Mar 31, 2020 |
15.21% |
| Dec 31, 2019 |
-21.66% |
| Sep 30, 2019 |
3.38% |
| Jun 30, 2019 |
-33.68% |
| Mar 31, 2019 |
-32.78% |
| Dec 31, 2018 |
3.85% |
| Sep 30, 2018 |
-5.89% |
| Jun 30, 2018 |
-10.56% |
| Mar 31, 2018 |
16.01% |
| Dec 31, 2017 |
-0.49% |
| Sep 30, 2017 |
32.10% |
| Jun 30, 2017 |
-13.98% |
| Mar 31, 2017 |
26.04% |
| Dec 31, 2016 |
53.80% |
| Sep 30, 2016 |
-9.40% |
| Jun 30, 2016 |
-21.01% |
| Mar 31, 2016 |
28.96% |
| Dec 31, 2015 |
-29.22% |
| Sep 30, 2015 |
7.12% |
| Jun 30, 2015 |
53.41% |
| Mar 31, 2015 |
40.62% |
| Dec 31, 2014 |
61.51% |
| Sep 30, 2014 |
57.54% |
| Jun 30, 2014 |
42.54% |
| Mar 31, 2014 |
8.87% |
| Dec 31, 2013 |
166.99% |
| Sep 30, 2013 |
5.29% |
| Jun 30, 2013 |
-34.59% |
| Mar 31, 2013 |
7.61% |
| Dec 31, 2012 |
-55.00% |
| Sep 30, 2012 |
82.57% |
| Jun 30, 2012 |
55.91% |
| Mar 31, 2012 |
-10.97% |
| Dec 31, 2011 |
-25.52% |
| Sep 30, 2011 |
-27.74% |
| Jun 30, 2011 |
1.87% |
| Mar 31, 2011 |
13.55% |
| Dec 31, 2010 |
8.76% |
| Sep 30, 2010 |
-36.31% |
| Jun 30, 2010 |
-9.94% |
| Mar 31, 2010 |
10.38% |
